Literature DB >> 11572137

Clinical recognition and management of patients exposed to biological warfare agents.

D R Franz1, P B Jahrling, D J McClain, D L Hoover, W R Byrne, J A Pavlin, G W Christopher, T J Cieslak, A M Friedlander, E M Eitzen.   

Abstract

Concern regarding the use of biological agents (bacteria, viruses, or toxins) as tools of warfare or terrorism has led to measures to deter their use or, failing that, to deal with the consequences. Unlike chemical agents, which typically lead to severe disease syndromes within minutes at the site of exposure, diseases resulting from biological agents have incubation periods of days. Rather than a paramedic, it will likely be a physician who is first faced with evidence of the results of a biological attack. Provided here is an updated primer on 11 classic BW and potential terrorist agents to increase the likelihood of their being considered in a differential diagnosis. Although the resultant diseases are rarely seen in many countries today, accepted diagnostic and epidemiologic principles apply; if the cause is identified quickly, appropriate therapy can be initiated and the impact of a terrorist attack greatly reduced.

Entities:  

Mesh:

Year:  2001        PMID: 11572137

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN: 0272-2712            Impact factor:   1.935


  16 in total

1.  A DNA vaccine for venezuelan equine encephalitis virus delivered by intramuscular electroporation elicits high levels of neutralizing antibodies in multiple animal models and provides protective immunity to mice and nonhuman primates.

Authors:  Lesley C Dupuy; Michelle J Richards; Barry Ellefsen; Lillian Chau; Alain Luxembourg; Drew Hannaman; Brian D Livingston; Connie S Schmaljohn
Journal:  Clin Vaccine Immunol       Date:  2011-03-30

2.  Human leukocyte antigen-DQ8 transgenic mice: a model to examine the toxicity of aerosolized staphylococcal enterotoxin B.

Authors:  Chad J Roy; Kelly L Warfield; Brent C Welcher; Raoul F Gonzales; Tom Larsen; Julie Hanson; Chella S David; Theresa Krakauer; Sina Bavari
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

3.  Pathology and pathophysiology of inhalational anthrax in a guinea pig model.

Authors:  Vladimir Savransky; Daniel C Sanford; Emily Syar; Jamie L Austin; Kevin P Tordoff; Michael S Anderson; Gregory V Stark; Roy E Barnewall; Crystal M Briscoe; Laurence Lemiale-Biérinx; Sukjoon Park; Boris Ionin; Mario H Skiadopoulos
Journal:  Infect Immun       Date:  2013-01-28       Impact factor: 3.441

Review 4.  Bioterrorism and the nervous system.

Authors:  M H Han; J R Zunt
Journal:  Curr Neurol Neurosci Rep       Date:  2003-11       Impact factor: 6.030

5.  A rhesus macaque (Macaca mulatta) model of aerosol-exposure brucellosis (Brucella suis): pathology and diagnostic implications.

Authors:  Samuel L Yingst; Louis M Huzella; Lara Chuvala; Mark Wolcott
Journal:  J Med Microbiol       Date:  2010-03-11       Impact factor: 2.472

6.  Development of CMX001 for the Treatment of Poxvirus Infections.

Authors:  Randall Lanier; Lawrence Trost; Tim Tippin; Bernhard Lampert; Alice Robertson; Scott Foster; Michelle Rose; Wendy Painter; Rose O'Mahony; Merrick Almond; George Painter
Journal:  Viruses       Date:  2010-12       Impact factor: 5.048

Review 7.  Development of Nanosensors Based Intelligent Packaging Systems: Food Quality and Medicine.

Authors:  Ramachandran Chelliah; Shuai Wei; Eric Banan-Mwine Daliri; Momna Rubab; Fazle Elahi; Su-Jung Yeon; Kyoung Hee Jo; Pianpian Yan; Shucheng Liu; Deog Hwan Oh
Journal:  Nanomaterials (Basel)       Date:  2021-06-08       Impact factor: 5.076

8.  Prophylaxis after exposure to Coxiella burnetii.

Authors:  Claire E Moodie; Herbert A Thompson; Martin I Meltzer; David L Swerdlow
Journal:  Emerg Infect Dis       Date:  2008-10       Impact factor: 6.883

9.  A Multiagent Alphavirus DNA Vaccine Delivered by Intramuscular Electroporation Elicits Robust and Durable Virus-Specific Immune Responses in Mice and Rabbits and Completely Protects Mice against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenges.

Authors:  Lesley C Dupuy; Michelle J Richards; Brian D Livingston; Drew Hannaman; Connie S Schmaljohn
Journal:  J Immunol Res       Date:  2018-06-03       Impact factor: 4.818

10.  Nanoscale Phenotypic Textures of Yersinia pestis Across Environmentally-Relevant Matrices.

Authors:  Kanwal M Iqbal; Massimo F Bertino; Muhammed R Shah; Christopher J Ehrhardt; Vamsi K Yadavalli
Journal:  Microorganisms       Date:  2020-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.